Menu
 
Research menu
Jump to menu

Publications:  Dr Kirtiman Srivastava

Dakir E-H, Pickard A, SRIVASTAVA K, McCrudden CM, Gross SR, Lloyd S, Zhang S-D, Margariti A et al.(2018). The anti-psychotic drug pimozide is a novel chemotherapeutic for breast cancer. Oncotarget vol. 9, (79) 34889-34910.
10.18632/oncotarget.26175
https://qmro.qmul.ac.uk/xmlui/handle/123456789/54263
SRIVASTAVA K, Pickard A, Craig SG, Quinn GP, Lambe SM, James JA, McDade SS, McCance DJ(2018). ΔNp63γ/SRC/Slug Signaling Axis Promotes Epithelial-to-Mesenchymal Transition in Squamous Cancers. Clinical Cancer Research
10.1158/1078-0432.CCR-17-3775
Bill MA, Srivastava K, Breen C, Butterworth KT, McMahon SJ, Prise KM, McCloskey KD(2017). Dual effects of radiation bystander signaling in urothelial cancer: purinergic-activation of apoptosis attenuates survival of urothelial cancer and normal urothelial cells. Oncotarget vol. 8, (57) 97331-97343.
10.18632/oncotarget.21995
SRIVASTAVA K, Bayraktutan U(2017). Suppression of protein kinase C-α ameliorates hyperglycaemia-evoked in vitro cerebral barrier dysfunction. Stroke Research and Therapy vol. 2, (1)
SRIVASTAVA K, Pickard A, McDade S, McCance DJ(2015). p63 drives invasion in keratinocytes expressing HPV16 E6/E7 genes through regulation of Src-FAK signalling. Oncotarget vol. 8, (10) 16202-16219.
10.18632/oncotarget.3892.
Rakkar K, SRIVASTAVA K, Bayraktutan U(2014). Attenuation of urokinase activity during experimental ischaemia protects the cerebral barrier from damage through regulation of matrix metalloproteinase-2 and NAD(P)H oxidase. European Journal of Neuroscience vol. 39, (12)
10.1111/ejn.12552
Gibson CL, SRIVASTAVA K, Spring N, Bath PM, Bayraktutan U(2014). Inhibition of Rho-kinase protects cerebral barrier from ischemia-evoked injury through modulations of endothelial cell oxidative stress and tight junctions. Journal of Neurochemistry vol. 129, (5)
10.1111/jnc.12681
SRIVASTAVA K, Shao B, Bayraktutan U(2013). PKC-β exacerbates in vitro brain barrier damage in hyperglycemic settings via regulation of RhoA/Rho-kinase/MLC2 pathway. Journal of Cerebral Blood Flow and Metabolism vol. 33, (12)
10.1038/jcbfm.2013.151
Srivastava K, Bath PMW, Bayraktutan U(2011). Current Therapeutic Strategies to Mitigate the eNOS Dysfunction in Ischaemic Stroke. Cellular and Molecular Neurobiology vol. 32, (3) 319-336.
10.1007/s10571-011-9777-z
Allen C, Srivastava K, Bayraktutan U(2010). Small GTPase RhoA and Its Effector Rho Kinase Mediate Oxygen Glucose Deprivation-Evoked In Vitro Cerebral Barrier Dysfunction. Stroke vol. 41, (9) 2056-2063.
10.1161/strokeaha.109.574939
Return to top